{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:10:01Z","timestamp":1767705001055,"version":"3.40.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T00:00:00Z","timestamp":1361145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056870","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T23:44:31Z","timestamp":1361231071000},"page":"e56870","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Valeria","family":"Capurro","sequence":"first","affiliation":[]},{"given":"Perrine","family":"Busquet","sequence":"additional","affiliation":[]},{"given":"Joao Pedro","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Rosalia","family":"Bertorelli","sequence":"additional","affiliation":[]},{"given":"Glauco","family":"Tarozzo","sequence":"additional","affiliation":[]},{"given":"Maria Laura","family":"Bolognesi","sequence":"additional","affiliation":[]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[]},{"given":"Angelo","family":"Reggiani","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Cavalli","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7355_2007_017","article-title":"Therapeutic Approaches for the Treatment of Alzheimer's Disease: An Overview","volume":"2","author":"LF Lau","year":"2008","journal-title":"Top Med Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"RT Bartus","year":"1982","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2040622310382817","article-title":"Frontiers in Alzheimer's disease therapeutics","volume":"2","author":"JG Stone","year":"2011","journal-title":"Ther Adv Chronic Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"JA Hardy","year":"1992","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"E Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/187152711794480474","article-title":"Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease","volume":"10","author":"HH Palacios","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.3233\/JAD-2010-100564","article-title":"Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons","volume":"20","author":"M Manczak","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"RA Smith","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-3-7091-7508-8_30","article-title":"Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study","author":"H Gutzmann","year":"1998","journal-title":"J Neural Transm"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.ajpath.2011.07.004","article-title":"Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain","volume":"179","author":"KJ Kopeikina","year":"2011","journal-title":"Am J Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1523\/JNEUROSCI.0858-11.2011","article-title":"Controlled cortical impact traumatic brain injury in 3\u00d7Tg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities","volume":"31","author":"HT Tran","year":"2011","journal-title":"J Neurosci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"A Cavalli","year":"2008","journal-title":"J Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cbpa.2009.04.619","article-title":"Alzheimer's disease: new approaches to drug discovery","volume":"13","author":"ML Bolognesi","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/anie.200700256","article-title":"A small molecule targeting the multifactorial nature of Alzheimer's disease","volume":"46","author":"A Cavalli","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.2174\/156802611798184373","article-title":"Multitarget-directed ligands: innovative chemical probes and therapeutic tools against Alzheimer's disease","volume":"11","author":"ML Bolognesi","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nurt.2008.10.042","article-title":"Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease","volume":"6","author":"ML Bolognesi","year":"2009","journal-title":"Neurotherapeutics"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Cavalli A, Bolognesi ML (2012) Multitargeted Drugs for Treatment of Alzheimer's Disease. Polypharmacology in Drug Discovery: John Wiley & Sons, Inc. pp. 441\u2013458.","DOI":"10.1002\/9781118098141.ch22"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1016\/j.bmcl.2011.07.091","article-title":"Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Abeta-aggregation inhibitors: Synthesis and biological evaluation","volume":"21","author":"T Mohamed","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.bmcl.2010.12.093","article-title":"Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity","volume":"21","author":"ML Bolognesi","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref20","unstructured":"Paxinos G, Franklin KBJ (2007) Mouse Brain in Stereotaxic Coordinates: Academic press."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1460-9568.2003.02725.x","article-title":"Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors","volume":"18","author":"A Tschenett","year":"2003","journal-title":"Eur J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3233\/JAD-2008-15407","article-title":"Apparent behavioral benefits of tau overexpression in P301L tau transgenic mice","volume":"15","author":"D Morgan","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbr.2003.08.004","article-title":"The T-maze continuous alternation task for assessing the effects of putative cognition enhancers in the mouse","volume":"151","author":"L Spowart-Manning","year":"2004","journal-title":"Behav Brain Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"CV Vorhees","year":"2006","journal-title":"Nat Protoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nprot.2006.205","article-title":"Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u2018recognition memory\u2019","volume":"1","author":"RA Bevins","year":"2006","journal-title":"Nat Protoc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-3565(25)12928-5","article-title":"Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine","volume":"277","author":"GM Bores","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1046\/j.1460-9568.2003.02546.x","article-title":"Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides","volume":"17","author":"P Agostinho","year":"2003","journal-title":"Eur J Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1021\/jm070559a","article-title":"Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease","volume":"50","author":"ML Bolognesi","year":"2007","journal-title":"J Med Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(03)03369-9","article-title":"Antioxidant activity of X-34 in synaptosomal and neuronal systems","volume":"988","author":"J Kanski","year":"2003","journal-title":"Brain Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2008.06.036","article-title":"Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1\u201342: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death","volume":"155","author":"R Resende","year":"2008","journal-title":"Neuroscience"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/brain\/awr189","article-title":"The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships","volume":"134","author":"JS Snowden","year":"2011","journal-title":"Brain"},{"key":"ref32","unstructured":"Tulving E (1972) In:Tulving E, Donaldson W, editors. Organization of Memory: Academic Press pp. 381\u2013402."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.lfs.2010.09.004","article-title":"Assessment of spatial memory in mice","volume":"87","author":"S Sharma","year":"2010","journal-title":"Life Sci"},{"key":"ref34","unstructured":"O'Keefe J, Nadel L (1978) The Hippocampus as a Cognitive Map.: Oxford University Press."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pbb.2011.05.017","article-title":"Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats","volume":"99","author":"N Gacar","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neubiorev.2007.01.005","article-title":"The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents","volume":"31","author":"E Dere","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.npp.1300080","article-title":"Modulation of passive avoidance in mice by the 5-HT1A receptor agonist flesinoxan: comparison with the benzodiazepine receptor agonist diazepam","volume":"28","author":"M Tsuji","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2003.08.026","article-title":"Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade","volume":"477","author":"C Mazzola","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd2075","article-title":"Drug discovery in dementia: the role of rodent models","volume":"5","author":"D Van Dam","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pbb.2010.08.005","article-title":"Anti-amnesic effect of ESP-102 on Abeta(1\u201342)-induced memory impairment in mice","volume":"97","author":"DH Kim","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2012.10.033","article-title":"The gamma-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Abeta(1\u201342) seeding and short-term memory deficits in the Abeta(25\u201335) mouse model of Alzheimer's disease","volume":"698","author":"J Meunier","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43)","volume":"13","author":"T Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25\u201335 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"J Meunier","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1152\/physiol.00024.2010","article-title":"Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease","volume":"26","author":"PH Axelsen","year":"2011","journal-title":"Physiology (Bethesda)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"JL Bolton","year":"2000","journal-title":"Chem Res Toxicol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/jo7024543","article-title":"The unusual reaction of semiquinone radicals with molecular oxygen","volume":"73","author":"L Valgimigli","year":"2008","journal-title":"J Org Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/135100099101534701","article-title":"Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease","volume":"4","author":"AK Raina","year":"1999","journal-title":"Redox Rep"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0197-4580(03)00117-9","article-title":"Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease","volume":"25","author":"KS SantaCruz","year":"2004","journal-title":"Neurobiol Aging"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Wang Y, Santa-Cruz K, DeCarli C, Johnson JA (2000) NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. 525\u2013531 p.","DOI":"10.1016\/S0197-4580(00)00114-7"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1016\/j.febslet.2005.09.006","article-title":"One-compound-multiple-targets strategy to combat Alzheimer's disease","volume":"579","author":"HY Zhang","year":"2005","journal-title":"FEBS Lett"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:34:01Z","timestamp":1745962441000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056870"}},"subtitle":[],"editor":[{"given":"Stefano L.","family":"Sensi","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,2,18]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056870","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2013,2,18]]}}}